查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
人類原代細胞市場：按產品類型、按分離、按細胞類型、按應用、按國家、按地區 - 行業分析、市場規模、市場份額、預測 2023-2030
市場調查報告書
商品編碼
1299773

人類原代細胞市場：按產品類型、按分離、按細胞類型、按應用、按國家、按地區 - 行業分析、市場規模、市場份額、預測 2023-2030

Human Primary Cells Market with COVID-19 Impact Analysis, By Product Type, By Separation, By Cell Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 323 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年人類原代細胞市場規模將達到 13.607 億美元，2023 年至 2030 年復合年增長率為 11.5%

人類原代細胞市場 - 市場動態：

在原代細胞市場增長的背景下，有老年人口的增加、研發的進步、慢性病患者的增加。 此外，醫藥市場在先進測試和藥物開發方面正在顯著增長。 因此，人類原代細胞市場的採用預計將會增加。 然而，原材料供應有限和昂貴的工藝是預測期內阻礙市場增長的主要因素。

此外，原代細胞培養物還可用於鑑定新藥的細胞毒性。 此外，原代人類細胞被用作動物模型的替代品來測試化學品、化妝品和新藥的效果。 這些是預計推動市場增長的主要因素。 COVID-19 大流行對人類原代細胞市場產生了積極影響。 研究人員利用人類原代細胞來了解傳染病。 特徵化和標準化的上皮細胞培養模型正在幫助我們了解冠狀病毒破壞的物理屏障。 該模型將有助於模擬呼吸系統的特性和功能，為將研究成果轉化為醫學應用提供突破。

人類原代細胞市場 - 細分分析：

全球人類原代細胞市場根據產品類型、分離、細胞類型、應用和地區進行細分。

按照產品類型，市場分為三個部分：人類原代細胞、試劑和補充劑以及培養基。 試劑和補充劑領域預計將主導市場。 人類原代細胞參與試劑和補充劑製造和研究的常規應用。 由於人類原代細胞生長脆弱，試劑和補充劑被認為非常重要。

根據分離，市場分為提取、□法分離、機械分離等。 在預測期內，□降解可能會保持其主導地位。 與其他分離原代人類細胞的技術相比，□消化因其速度相對較快、代表性樣品產量高以及對培養物損傷較小等優點而受到重視。原因之一是

市場按細胞類型分為動物和人類。 預計動物細分市場將佔據最大的市場份額。 越來越多地使用動物源性人類原代細胞來開發疫苗是推動該領域發展的關鍵因素。

市場按應用細分為組織培養/組織工程、疫苗製造、基因治療/再生醫學、毒性測試/藥物篩選、病毒學、癌症研究、幹細胞治療、模型系統、產前診斷和其他 9 個類別. 分類為 預計疫苗生產領域將在預測期內主導市場。 動物原代培養物越來越多地用於生產用於生產各種疫苗的病毒，包括乙型肝炎和麻疹疫苗。

人類原代細胞市場 - 競爭格局：

由於對研發活動的大力投資，通過使用人類原代細胞來治療各種免疫缺陷疾病來開發更好的治療方法，人類原代細胞市場在全球範圍內迅速增長。 此外，隨著生物製藥和生物技術領域的發展，醫學研究人員不斷探索利用來自人類和動物組織的原代細胞來治療惡性癌症。 此外，主要參與者正在採取新產品發布、併購、研發支出、合作夥伴關係和聯盟等策略來增加市場收入。 例如，2021 年 8 月，Axol Bioscience Ltd 宣布與 CENSO Biotechnologies 合併。 合併後的實體將成為服務解決方案和產品的領先提供商。 此外，它將為客戶提供一整套服務，包括經過驗證的、即用型細胞系、強大的功能數據、定制能力和廣泛的專業知識，並且交貨時間更短。

研究的主要特點

這份關於人類原代細胞市場的研究報告提供了以2022年為基準年的市場規模、複合年增長率（CAGR%）、估計和預測（2023-2030年）。

本研究報告闡明了不同細分市場/國家的潛在增長機會，並描述了人類原代細胞市場有吸引力的投資主張矩陣。

總體報告確定了新的投資機會、現有企業面臨的挑戰以及人類原代細胞市場可持續發展的增長動力。

研究範圍詳細討論了 COVID-19 對人類原代細胞市場規模、預測、複合年增長率和市場動態的影響。 它還涵蓋了對新冠疫情後人類原代細胞市場的詳細見解。

為了向本報告的用戶提供對人類原代細胞市場的全面了解，我們還對人類原代細胞市場進行了競爭格局和關鍵創新者分析。

本報告涵蓋了增長前景映射分析，根據市場規模、增長率和吸引力對所有行業領域進行基準測試。

該報告提供了主要市場參與者的詳細公司概況，以幫助您了解在人類原代細胞市場運營的公司的財務信息和戰略舉措。

報告還揭示了市場主要進入者不僅在全球層面而且在區域層面的重大收購和兼併、聯盟和合資企業、新產品推出、研發和區域擴張。Masu。

全球人類原代細胞市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和財務分析師。

內容

第一章人類原代細胞市場概述

  • 調查範圍

第 2 章執行摘要

  • 市場細分
  • 競爭考慮因素

第三章人類原代細胞主要市場趨勢

  • 人類原代細胞市場驅動因素
  • 人原代細胞市場製約因素
  • 人類原代細胞的市場機會
  • 人類原代細胞市場的未來趨勢

第四章人體原代細胞產業研究

  • PEST分析
  • 波特五力分析
  • 增長前景圖
  • 監管框架分析

第五章人類原代細胞市場：COVID-19 的影響分析

  • 新冠肺炎 (COVID-19) 疫情爆發前的影響分析
  • 新冠肺炎 (COVID-19) 疫情後的影響分析

第六章人類原代細胞市場情況

  • 2022 年人類原代細胞市場份額分析
  • 主要製造商的詳細數據
    • 已成立公司分析
    • 初創企業分析

第 7 章人類原代細胞市場 - 按產品類型

  • 概述
    • 按產品類型分析細分市場份額
    • 人類原代細胞
    • 試劑和補充劑
    • 媒體

第 8 章人類原代細胞市場 - 通過隔離

  • 概述
    • 按細分市場劃分的細分市場份額分析
    • 外植體法
    • □降解
    • 機械分離
    • 其他

第 9 章主要人類細胞市場 - 按細胞類型

  • 概述
    • 按細胞類型劃分的細分市場份額分析
    • 動物
    • 人類

第 10 章主要人類細胞市場 - 按應用

  • 概述
    • 按應用劃分的細分市場份額分析
    • 組織培養和組織工程
    • 疫苗生產
    • 基因治療和再生醫學
    • 毒性測試和藥物篩選
    • 癌症研究
    • 幹細胞療法
    • 模型系統
    • 產前診斷
    • 其他

第 11 章主要人類細胞市場 - 按地區

  • 簡介
  • 北美
    • 概述
    • 北美原代人體細胞的主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲原代人體細胞的主要製造商
    • 德國
    • 意大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 其他
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區主要人類原代細胞製造商
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印度尼西亞
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲領先的主要人體細胞製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲
    • 概述
    • 中東和非洲人類原代細胞的主要製造商
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第 12 章主要供應商分析 - 人類原代細胞行業

  • 競賽儀表板
  • 公司簡介
    • Merck Group
    • ATCC
    • Thermo Fisher Scientific Inc
    • Sigma-Aldrich Co.
    • Charles River Laboratories
    • Merck Group
    • Axol Bioscience
    • ReachBio Research Labs
    • STEMCELL Technologies Inc
    • Lonza
    • Cell Biologics, Inc.
    • PromoCell-Human Centered Science
    • ZenBio, Inc.
    • AllCells

第十三章分析師的全面觀點

Product Code: ANV1363

REPORT HIGHLIGHT

Human Primary Cells market size was valued at USD 1,360.7 Million in 2022, expanding at a CAGR of 11.5% from 2023 to 2030.

Human Primary Cells are also known as mature cells extracted from living tissues of humans and animals after that processed to establish them for utilization in appropriate cell therapies. Additionally, Human Primary Cells are also used in several applications such as cancer research, 3D cell culture, tissue replacement, stem cell therapy, and virology. 3D cell culture is increasingly used by researchers to study cell biology and biochemistry, cell-pathogen interactions, drug effects, and cell signaling.

Human Primary Cells Market- Market Dynamics:

The primary cell market growth is attributed to the increasing geriatric population, advancements in development and research, and a rise in cases of chronic diseases. Additionally pharmaceutical market is growing significantly in advanced testing and drug development. This in turn projected to facilitate increased adoption of the Human Primary Cells market. However, restrictions implemented for the utilization of raw materials and expensive processes are the major factors hindering the market growth during the forecast period.

Moreover, primary cell cultures are used to identify the cytotoxicity of new drugs. Furthermore, Human Primary Cells are used in the place of animal models to test the effects of chemicals, cosmetics, and new drugs. These are some major factors expected to drive market growth. The COVID-19 pandemic has impacted the Human Primary Cells market positively. Human Primary Cells are used by researchers for understanding the infection. Characterized and standardized epithelium cell culture models are helping to understand the physical barrier devastated by the coronavirus. The models can assist mimic the properties and functions of the respiratory tract which leads to a breakthrough for a research outcome moving into a medical application

Human Primary Cells Market- Segmentation Analysis:

The global Human Primary Cells market is segmented on the basis of product type, separation, cell type, application, and region.

The market is divided into three categories based on product type: Human Primary Cells, reagents and supplements, and media. The reagents and supplements sector is expected to possess the market. Human Primary Cells are involved in reagents and supplements' routine application in manufacturing and research. The reagents and supplements are considered very crucial as Human Primary Cells are fragile for their growth.

The market is divided into three categories based on separation: explant method, enzymatic degradation, mechanical separation, and others. The enzymatic degradation sector is likely to maintain its dominance during the forecast period. This is partly due to its high preference at the place of other techniques for the separation of Human Primary Cells owing to its advantages such as comparatively fast, high yield of a representative sample, and less damage to cultures.

The market is divided into two categories based on cell type: animal and human. The animal sector is expected to hold the largest market share. For vaccine development, increasing the application of animal-origin Human Primary Cells are essential factor propelling the segment growth.

The market is divided into nine categories based on application: tissue culture & tissue engineering, vaccine production, gene therapy and regenerative medicine, toxicity testing & drug screening, virology, cancer research, stem cell therapy, model system, prenatal diagnosis, and others. The vaccine production sector is expected to dominate the market over the forecast period. Rising use of primary animal culture for the production of virus that is later utilized for producing various vaccines including hepatitis B and measles.

Human Primary Cells Market-Competitive Landscape:

The Human Primary Cells market is rapidly driven globally by robust investment in research and development activities for the increment of better therapies where Human Primary Cells can be utilized to treat various immunodeficiency disorders. Additionally, with The growth in biopharmaceutical and biotechnology sectors, medical researchers are continuously working on using Human Primary Cells from human and animal tissues for the treatment of malignant cancers. Moreover, key players are adopting strategies such as new product launches, mergers & acquisitions, R&D spending, partnerships, and collaboration to enhance their market revenue. For instance, in August 2021, Axol Bioscience Ltd announced its merger with CENSO Biotechnologies. The merged entity will become a leading provider of service solutions and products. Additionally, it will provide customers with validated ready-to-use cell lines and a suite of services with robust functional data, customization capabilities, and broader expertise, all with shorter lead times.

Key features of the study:

This proposed research study on Human Primary Cells market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.

The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Human Primary Cells market.

The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Human Primary Cells market.

Impact of COVID-19 on Human Primary Cells market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Human Primary Cells market post-COVID will also be covered.

In order to give the users of this report a comprehensive view on the Human Primary Cells market, we have also included competitive landscape and key innovator analysis for Human Primary Cells market.

The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.

The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the Human Primary Cells market.

In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.

The global Human Primary Cells market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN PRIMARY CELLS MARKET KEY PLAYERS

  • Merck Group
  • ATCC
  • Thermo Fisher Scientific Inc
  • Sigma-Aldrich Co.
  • Charles River Laboratories
  • Merck Group
  • Axol Bioscience
  • ReachBio Research Labs
  • STEMCELL Technologies Inc
  • Lonza
  • Cell Biologics, Inc.
  • PromoCell - Human Centered Science
  • ZenBio, Inc.
  • AllCells

GLOBAL HUMAN PRIMARY CELLS MARKET, BY PRODUCT TYPE

  • Human Primary Cells
  • Reagents and Supplements
  • Media

GLOBAL HUMAN PRIMARY CELLS MARKET, BY SEPARATION

  • Explant Method
  • Enzymatic Degradation
  • Mechanical Separation
  • Others

GLOBAL HUMAN PRIMARY CELLS MARKET, BY CELL TYPE

  • Animal
  • Human

GLOBAL HUMAN PRIMARY CELLS MARKET, BY APPLICATION

  • Tissue Culture & Tissue Engineering
  • Vaccine Production
  • Gene Therapy and Regenerative Medicine
  • Toxicity Testing and Drug Screening
  • Cancer Research
  • Stem Cell Therapy
  • Model System
  • Prenatal Diagnosis
  • Others

GLOBAL HUMAN PRIMARY CELLS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Primary Cells Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Primary Cells Market Snippet by Product Type
    • 2.1.2. Human Primary Cells Market Snippet by Separation
    • 2.1.3. Human Primary Cells Market Snippet by Cell Type
    • 2.1.4. Human Primary Cells Market Snippet by Application
    • 2.1.5. Human Primary Cells Market Snippet by Country
    • 2.1.6. Human Primary Cells Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Primary Cells Key Market Trends

  • 3.1. Human Primary Cells Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Primary Cells Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Primary Cells Market Opportunities
  • 3.4. Human Primary Cells Market Future Trends

4. Human Primary Cells Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Primary Cells Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Human Primary Cells Market Landscape

  • 6.1. Human Primary Cells Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Primary Cells Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Human Primary Cells
    • 7.1.3. Reagents and Supplements
    • 7.1.4. Media

8. Human Primary Cells Market - By Separation

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Separation, 2022&2030 (%)
    • 8.1.2. Explant Method
    • 8.1.3. Enzymatic Degradation
    • 8.1.4. Mechanical Separation
    • 8.1.5. Others

9. Human Primary Cells Market - By Cell Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Cell Type, 2022&2030 (%)
    • 9.1.2. Animal
    • 9.1.3. Human

10. Human Primary Cells Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 10.1.2. Tissue Culture & Tissue Engineering
    • 10.1.3. Vaccine Production
    • 10.1.4. Gene Therapy and Regenerative Medicine
    • 10.1.5. Toxicity Testing and Drug Screening
    • 10.1.6. Cancer Research
    • 10.1.7. Stem Cell Therapy
    • 10.1.8. Model System
    • 10.1.9. Prenatal Diagnosis
    • 10.1.10. Others

11. Human Primary Cells Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Human Primary Cells Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Human Primary Cells Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Human Primary Cells Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Human Primary Cells Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Human Primary Cells Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Separation, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Cell Type, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Human Primary Cells Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Merck Group
    • 12.2.2. ATCC
    • 12.2.3. Thermo Fisher Scientific Inc
    • 12.2.4. Sigma-Aldrich Co.
    • 12.2.5. Charles River Laboratories
    • 12.2.6. Merck Group
    • 12.2.7. Axol Bioscience
    • 12.2.8. ReachBio Research Labs
    • 12.2.9. STEMCELL Technologies Inc
    • 12.2.10. Lonza
    • 12.2.11. Cell Biologics, Inc.
    • 12.2.12. PromoCell - Human Centered Science
    • 12.2.13. ZenBio, Inc.
    • 12.2.14. AllCells

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Human Primary Cells Market: Product Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product Type
  • TABLE Global Human Primary Cells Market, by Product Type2018-2030 (USD Million)
  • TABLE Human Primary Cells Market: SeparationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Separation
  • TABLE Global Human Primary Cells Market, by Separation2018-2030 (USD Million)
  • TABLE Human Primary Cells Market: Regional snapshot (2022)
  • TABLE Human Primary Cells Market: Cell Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Cell Type
  • TABLE Global Human Primary Cells Market, by Cell Type 2018-2030 (USD Million)
  • TABLE Human Primary Cells Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Human Primary Cells Market, by Application2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Human Primary Cells Market, by Region 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE North America Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE EuropeHuman Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Europe Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Latin America Human Primary Cells Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Product Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Separation, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Cell Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Primary Cells Market, by Application, 2018-2030 (USD Million)